期刊
ACS CHEMICAL BIOLOGY
卷 15, 期 10, 页码 2655-2661出版社
AMER CHEMICAL SOC
DOI: 10.1021/acschembio.0c00093
关键词
-
资金
- American Diabetes Association Pathway to Stop Diabetes Grant [1-17- VSN-04]
- SENS Research Foundation
- National Institute of Health Yale Chemical Biology Training Grant [2T32GM06754 3-17]
Although there is ample evidence that the advanced glycation end-product (AGE) glucosepane contributes to age-related morbidities and diabetic complications, the impact of glucosepane modifications on proteins has not been extensively explored due to the lack of sufficient analytical tools. Here, we report the development of the first polyclonal anti-glucosepane antibodies using a synthetic immunogen that contains the core bicydic ring structure of glucosepane. We investigate the recognition properties of these antibodies through ELISAs involving an array of synthetic AGE derivatives and determine them to be both high-affinity and selective in binding glucosepane. We then employ these antibodies to image glucosepane in aging mouse retinae via immunohistochemistry. Our studies demonstrate for the first time accumulation of glucosepane within the retinal pigment epithelium, Brach's membrane, and choroid: all regions of the eye impacted by age-related macular degeneration. Co-localization studies further su est that glucosepane colocalizes with lipofuscin, which has previously been associated with lysosomal dysfunction and has been implicated in the development of age-related macular degeneration, among other diseases. We believe that the anti-glucosepane antibodies described in this study will prove highly useful for examining the role of glycation in human health and disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据